TMED ETF
T. Rowe Price Health Care ETF
TMED ETF Overview
TMED ETF (T. Rowe Price Health Care ETF) is managed by T.Rowe Price with $41.8M in net assets. TMED expense ratio is 0.44%, holding 116 positions across sectors including Health Care, Financials, Information Technology. Inception date: 2025-06-11.
TMED performance shows a YTD return of 15.60%. The 1-year return is 20.53%. TMED dividend yield stands at 0.46%, paid annually.
TMED top holdings include Eli Lilly & Co (6.2%), Unitedhealth Group Incorporated (5.2%), Insulet Corp (3.8%), Alnylam Pharmaceuticals Inc. (3.7%), Thermo Fisher (3.4%). Go to all TMED holdings, TMED sectors, or TMED dividends.
TMED can be compared against other funds. Use TMED overlap to find shared positions, or TMED vs another fund for a side-by-side view. TMED alternatives are available via the screener, along with tax-loss harvesting opportunities.